Profile
Michael L.
Gallo is the founder of A2 Biotherapeutics, Inc. He is currently the President of Innovative Targeting Solutions, Inc.
Michael L. Gallo active positions
| Companies | Position | Start |
|---|---|---|
Innovative Targeting Solutions, Inc.
 Innovative Targeting Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Innovative Targeting Solutions, Inc. develops human antibody therapeutics using its proprietary HuTARG technology. The HuTARG technology is a fully mammalian technology that generates antibody diversity in vitro via RAG1/RAG2 mediated V(D)J recombination. The company was founded in 20089 and is headquartered in Burnaby, Canada. | President | - |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Innovative Targeting Solutions, Inc.
Innovative Targeting Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Innovative Targeting Solutions, Inc. develops human antibody therapeutics using its proprietary HuTARG technology. The HuTARG technology is a fully mammalian technology that generates antibody diversity in vitro via RAG1/RAG2 mediated V(D)J recombination. The company was founded in 20089 and is headquartered in Burnaby, Canada. | Commercial Services |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Commercial Services |
- Stock Market
- Insiders
- Michael L. Gallo
